The present gold standard, bacterial blood cultures and susceptibility testing, requires days to obtain a result. The initial treatment
with empirical broad-spectrum antibiotics not only is inadequate but also promotes antimicrobial resistance AMR . The high mortality
of sepsis and AMR is partly due to the inability to rapidly detect and identify bacteria in the early stages of infection.
Benefits
directly lead to a rapid, sensitive, and specific test to detect and identify bacterial infection in blood. The test will enable
healthcare providers to prescribe an effective treatment of sepsis during its early stage before it becomes more dangerous.
Siamaf Healthcare Private Limited, Bengaluru, Karnataka
Accessibility Controls